EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia

Accumulating studies have proved EZH2 dysregulation mediated by mutation and expression in diverse human cancers including AML. However, the expression pattern of EZH2 remains controversial in acute myeloid leukaemia (AML). EZH1/2 expression and mutation were analysed in 200 patients with AML. EZH2...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Cell Mol Med
Hoofdauteurs: Chu, Ming‐qiang, Zhang, Ting‐juan, Xu, Zi‐jun, Gu, Yu, Ma, Ji‐chun, Zhang, Wei, Wen, Xiang‐mei, Lin, Jiang, Qian, Jun, Zhou, Jing‐dong
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2019
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6991666/
https://ncbi.nlm.nih.gov/pubmed/31794134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14855
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items